<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>RSS feed of www.actavis.no</title><link>http://www.actavis.no</link><description>RSS feed of www.actavis.no</description><ttl>60</ttl><item><title>Pressemelding 23.juni 2010</title><link>http://www.actavis.no/no/news/Pressemelding+23.juni+2010.htm</link><description>
		Reykjavik, 23.juni 2010 ― Actavis Group annonserte i dag at Dr. Claudio Albrect er blitt utnevnt til ny CEO. Den nye topplederen for Actavis har tidligere ledet Ratiopharm.  
Dr. Claudio Albrecht</description><category>Undefined</category><pubDate>Thu, 24 Jun 2010 12:01:14 GMT</pubDate><guid>{4340A9A7-1C5A-4385-9822-79DD6883B4CB}</guid></item><item><title>Actavis overtar drift av Inpac AS produksjonsbedrift på Lier</title><link>http://www.actavis.no/no/news/inpac_lier.htm</link><description>
		Actavis har i dag gjennomført en transaksjon med konkursboet til Inpac AS som sikrer drift av virksomheten på Lier ut året. 
Inpac AS, som er en av Actavis sine underleverandører, meldte oppbud</description><category>Other</category><pubDate>Fri, 30 Apr 2010 13:52:00 GMT</pubDate><guid>{295D9B25-2AF9-4CE6-A461-ABE057E70FFE}</guid></item><item><title>Aporex avregistreres</title><link>http://www.actavis.no/no/news/Aporex+withdrawn.htm</link><description>  
Virkestoffene i Aporex er dekstropropoksyfen og paracetamol. På grunn av bivirkningsproblemer anbefaler de europeiske legemiddelmyndighetene at legemidler med dekstropropoksyfen trekkes fra</description><category>Product</category><pubDate>Thu, 22 Apr 2010 14:58:35 GMT</pubDate><guid>{9FC3BD43-8039-4B94-A438-353D1AD799A1}</guid></item><item><title>The Romanian Medical Equipment and Supplies Market Is Expected To Grow At Between 7 And 10% per Annum Over the Coming Five Years</title><link>http://www.actavis.no/no/news/Expected+growth.htm</link><description>
		
DUBLIN, Ireland - (BUSINESS WIRE) - Research and Markets (http://www.researchandmarkets.com/reports/c88680) has announced the addition of Romania Pharmaceuticals and Healthcare Report Q2 2008 to</description><category>Other</category><pubDate>Mon, 14 Apr 2008 07:58:00 GMT</pubDate><guid>{AE2E91CE-E37E-4682-BE1F-F26AD4DF23BA}</guid></item><item><title>Actavis selger Norgesplaster til Sørlandsinvestorer</title><link>http://www.actavis.no/no/news/actavis_selger_norgesplaster.htm</link><description>
		Norgesplaster er ikke del av kjernevirksomheten til Actavis, og overtas med virkning fra januar 2010 av en gruppe Sørlandsinvestorer. De nye eierne er administrerende direktør Per Turnes samt</description><category>Other</category><pubDate>Mon, 01 Feb 2010 11:58:00 GMT</pubDate><guid>{7E2A4C94-D8A6-4CCE-9DAA-56DB34E5C0FA}</guid></item><item><title>Medisinbytte i apotek</title><link>http://www.actavis.no/no/news/Medisinbytte+i+apotek.htm</link><description>
		Statens legemiddelverk informerer på sine nettsider om medisinbytte i apotek. 
Når statens legemiddelverk garanterer at en medisin har samme medisinske virkning kan man trygt si ja når apoteket</description><category>Other</category><pubDate>Thu, 26 Mar 2009 15:57:00 GMT</pubDate><guid>{5B5CF5DD-61BD-43D0-A5BC-0003B1731AE4}</guid></item><item><title>Actavis receives approval of generic Wellbutrin SR® and Zyban® tablets in the US</title><link>http://www.actavis.no/no/news/Approval+of+generic+Wellbutrin+SR+and+Zyban.htm</link><description>
		 
Actavis has received two separate approvals from the US Food &amp; drug administration to market Bupropion Hydrochloride extended-release tablets (SR). Distribution of the products will commence</description><category>Product</category><pubDate>Sun, 23 Mar 2008 09:13:00 GMT</pubDate><guid>{23675C8D-79E3-454B-97B4-E52A59D76C2E}</guid></item><item><title>Actavis acquires API manufacturing company in China</title><link>http://www.actavis.no/no/news/Actavis+acquires+API+manufacturing+company+in+China.htm</link><description>
		
				
		
		
				Actavis has acquired a 90% share in Zhejiang Chiral Medicine Chemicals Company for an undisclosed amount. 
Strategic RationaleChiral is specialized in research, development</description><category>Other</category><pubDate>Wed, 09 Apr 2008 08:46:00 GMT</pubDate><guid>{83C82293-0BAB-4E37-A340-142B2C3AFBE4}</guid></item><item><title>Flux fluorskyll</title><link>http://www.actavis.no/no/news/flux+fluorskyll.htm</link><description>
		
				
						
Tidligere har du kjent Flux som fluortabletter. Flux fluorskyll inneholder den anbefalte mengden fluor på 0,05 prosent beregnet til daglig skylling. I tillegg inneholder den</description><category>Product</category><pubDate>Mon, 30 Apr 2007 17:04:00 GMT</pubDate><guid>{AD88EE78-66E8-4E27-A4BD-03D30242CC4A}</guid></item><item><title>Actavis Italy</title><link>http://www.actavis.no/no/news/Actavis+Italy.htm</link><description>
		Reykjavik, Iceland, 12 December 2007 
― Actavis Group, the international generic pharmaceuticals company has marketed its first own brand products in the Italian market. 
Italy, population 58</description><category>Other</category><pubDate>Tue, 11 Dec 2007 12:44:00 GMT</pubDate><guid>{C46967CD-1E70-4FD0-9D01-2EBEFDC1D6AA}</guid></item><item><title>News release</title><link>http://www.actavis.no/no/news/News+release.htm</link><description>
		
Actavis, den ledende internasjonale leverandøren av generiskelegemidler, annonserer i dag lansering av Bicalutamide tabletter i Norge. Bicalutamide fra Actavis er den første generiske versjonen</description><category>Product</category><pubDate>Wed, 12 Sep 2007 13:58:00 GMT</pubDate><guid>{F168CE66-40A0-428A-9DCF-525710DC52ED}</guid></item><item><title>Flux sjarmerer med ny reklamefilm</title><link>http://www.actavis.no/no/news/Flux+sjarmerer+med+ny+reklamefilm.htm</link><description>
		
 
Kreativt Forum har skrevet om Actavis sin Flux-satning på TV:

”Circus har laget en ny reklamefilm som skal styrke Flux.Flux på sin side skal fortsette å styrke tenner. 
At Flux er bra for</description><category>Product</category><pubDate>Tue, 05 May 2009 06:43:00 GMT</pubDate><guid>{09632EFB-2BD4-4E98-BF0F-341100E3C2AE}</guid></item><item><title>Actavis agreement with South Korea</title><link>http://www.actavis.no/no/news/Actavis+agreement+with+South+Korea.htm</link><description>
		
Seoul, South Korea, 30 October 2008― Actavis, the international generic pharmaceutical company, has entered into an exclusive distribution agreement, for a number of generic products, with J&amp;M</description><category>Commitment</category><pubDate>Fri, 31 Oct 2008 08:29:00 GMT</pubDate><guid>{24B6A967-4C1F-4DC3-9196-6B1D2863FDA2}</guid></item><item><title>Robert Wessman to present at annual UBS pharmaceuticals conference</title><link>http://www.actavis.no/no/news/Robert+Wessman+to+present+at+annual+UBS+pharmaceuticals+conference.htm</link><description>
		Actavis today announced that Robert Wessman, Actavis’ President &amp; CEO, will discuss “The strategy and competitiveness of Actavis in a fiercely competitive environment” at the annual UBS Global</description><category>Other</category><pubDate>Mon, 26 May 2008 11:18:00 GMT</pubDate><guid>{D0FA7E25-B40E-4119-9BEC-24E2560F7F04}</guid></item><item><title>lierfabrik</title><link>http://www.actavis.no/no/news/lierfabrik.htm</link><description>Actavis Group (ICEX: ACT), the international generic pharmaceuticals company, today announced that it has divested its manufacturing facility in Lier, Norway. In addition, the Group has secured a</description><category>Other</category><pubDate>Thu, 21 Dec 2006 10:51:00 GMT</pubDate><guid>{ACF50C82-D981-48BD-BAA8-D40A5FDC3FD9}</guid></item><item><title>Italy_press_release</title><link>http://www.actavis.no/no/news/Italy_press_release.htm</link><description>
		
				
						
								
										Reykjavik, Iceland, 12 December 2007 ― Actavis Group, the international generic pharmaceuticals company has marketed its first own brand products in the Italian</description><category>Product</category><pubDate>Tue, 11 Dec 2007 11:55:00 GMT</pubDate><guid>{5C17FAC2-9AF6-4BDE-9FC3-BF0AB2E29F01}</guid></item><item><title>Actavis launches its business in Ireland</title><link>http://www.actavis.no/no/news/Actavis+launches+its+business+in+Ireland.htm</link><description>
		Actavis has entered the Irish Market this week , with plans to create up to 25 new local jobs over the next five years and launch over 120 generic drugs in Irland., with the potential to save</description><category>Other</category><pubDate>Thu, 12 Mar 2009 08:01:00 GMT</pubDate><guid>{8AA694E2-E8CF-463C-A83B-39666CF9D74C}</guid></item><item><title>Actavis Group comments regarding Icelands financial crisis</title><link>http://www.actavis.no/no/news/Actavis+Group+comments+regarding+Icelands+financial+crisis.htm</link><description>
		
				
						In light of recent market events in the Icelandic financial sector, which are a consequence of the world financial crisis, Actavis Group would like to clarify its position.The</description><category>Other</category><pubDate>Mon, 27 Oct 2008 11:40:00 GMT</pubDate><guid>{E57EB3A9-803D-4890-B5B4-0FCD58EEEB65}</guid></item></channel></rss>